Aristeia Capital’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-124,625
Closed -$1.27M 432
2022
Q4
$1.27M Buy
+124,625
New +$1.26M 0.03% 308

Other funds holding PEPL

Aristeia Capital's PEPL Position: Q1 2023 in Review

Aristeia Capital sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 124,625 shares — an estimated $1.27M sold.

Aristeia Capital first reported a position in PEPL in Q4 2022 and held it in 1 quarter. The position peaked at $1.27M in Q4 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • Aristeia Capital reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Aristeia Capital sold 124,625 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $1.27M.
  • Aristeia Capital first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2022 and held it in 1 quarter.
  • Aristeia Capital's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $1.27M in Q4 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on Aristeia Capital's 13F filing for Q1 2023, filed 16 May 2023.